Congress has reintroduced the bipartisan PASTEUR Act of 2026 (Pioneering Antimicrobial Subscriptions to End Upsurging Resistance), landmark legislation designed to strengthen the antimicrobial pipeline and combat the growing threat of antimicrobial resistance.
The PASTEUR Act would create a subscription-based federal payment model for critically needed novel antibiotics and antifungals, helping ensure these lifesaving treatments remain available while supporting responsible antimicrobial stewardship. The legislation also includes investments in antimicrobial stewardship programs across hospitals, long-term care facilities, and outpatient settings; enhanced surveillance of antimicrobial resistance and antimicrobial use; and support for healthcare-associated infection prevention efforts.&nbsp;
Take one minute today to contact your senators and representative and ask them to co-sponsor the PASTEUR Act. Our goal is to generate as many new co-sponsors as possible. Congressional offices are more likely to support legislation when they hear directly from constituents, and every additional co-sponsor increases the likelihood that this critical legislation advances through Congress and becomes law.
 Current Congressional Co-Sponsors 
Alabama 
<ul>
<li>Rep. Terri A. Sewell (D-AL-7)&nbsp;&nbsp;</li>
</ul>
California 
<ul>
<li>Rep. Scott H. Peters (D-CA-50)&nbsp;&nbsp;</li>
<li>Rep. Mike Levin (D-CA-49)&nbsp;&nbsp;</li>
<li>Rep. David G. Valadao (R-CA-22)&nbsp;&nbsp;</li>
</ul>
Colorado 
<ul>
<li>Sen. John W. Hickenlooper (D-CO)&nbsp;&nbsp;</li>
</ul>
Florida 
<ul>
<li>Rep. Maria Elvira Salazar (R-FL-27)&nbsp;&nbsp;</li>
</ul>
Georgia 
<ul>
<li>Rep. Lucy McBath (D-GA-6)&nbsp;&nbsp;</li>
</ul>
Illinois 
<ul>
<li>Rep. Mike Quigley (D-IL-5)&nbsp;&nbsp;</li>
</ul>
Indiana 
<ul>
<li>Rep. Frank J. Mrvan (D-IN-1)&nbsp;&nbsp;</li>
<li>Sen. Todd Young (R-IN)&nbsp;&nbsp;</li>
</ul>
Maryland&nbsp;
<ul>
<li>Rep. Jamie Raskin (D-MD-8)&nbsp;&nbsp;</li>
</ul>
Massachusetts 
<ul>
<li>Rep. Jake Auchincloss (D-MA-4)&nbsp;&nbsp;</li>
</ul>
Minnesota 
<ul>
<li>Rep. Angie Craig (D-MN-2)&nbsp;&nbsp;</li>
</ul>
Nebraska 
<ul>
<li>Rep. Adrian Smith (R-NE-3)&nbsp;&nbsp;</li>
<li>Rep. Don Bacon (R-NE-2)&nbsp;&nbsp;</li>
</ul>
New Jersey 
<ul>
<li>Rep. Christopher H. Smith (R-NJ-4)&nbsp;&nbsp;</li>
<li>Rep. Josh Gottheimer (D-NJ-5)&nbsp;&nbsp;</li>
</ul>
New York 
<ul>
<li>Rep. Nicholas A. Langworthy (R-NY-23)&nbsp;&nbsp;</li>
<li>Rep. Yvette D. Clarke (D-NY-9)&nbsp;</li>
<li>Sen. Kirsten E. Gillibrand (D-NY)&nbsp;&nbsp;</li>
</ul>
North Carolina 
<ul>
<li>Rep. Deborah K. Ross (D-NC-2)&nbsp;&nbsp;</li>
<li>Rep. Donald G. Davis (D-NC-1)&nbsp;&nbsp;</li>
</ul>
Ohio 
<ul>
<li>Rep. Mike Carey (R-OH-15)&nbsp;&nbsp;</li>
</ul>
Pennsylvania 
<ul>
<li>Rep. Brian K. Fitzpatrick (R-PA-1)&nbsp;&nbsp;</li>
<li>Rep. Chrissy Houlahan (D-PA-6)&nbsp;&nbsp;</li>
<li>Rep. Daniel Meuser (R-PA-9)&nbsp;&nbsp;</li>
</ul>
South Dakota 
<ul>
<li>Sen. Mike Rounds (R-SD)&nbsp;&nbsp;</li>
</ul>
Tennessee 
<ul>
<li>Rep. Charles J. "Chuck" Fleischmann (R-TN-3)&nbsp;&nbsp;</li>
</ul>
Washington&nbsp;
<ul>
<li>Rep. Suzan K. DelBene (D-WA-1)&nbsp;&nbsp;</li>
</ul>

If your congressman is already a sponsor, they will not appear among the options for emailing letters.&nbsp;
Together, we can strengthen antimicrobial innovation, expand stewardship efforts across the continuum of care, and protect patients from the growing threat of antimicrobial resistance and drug-resistant infections. Take action today.

Urge Congress to Co-Sponsor the PASTEUR Act of 2026

As your constituent and a member of infection prevention and antimicrobial stewardship community (SHEA), I urge you to co-sponsor the PASTEUR Act (S.4875/H.R.7352). Antimicrobial resistance is one of the most serious threats to patient safety and public health facing Americans today. As bacteria increasingly become resistant to available treatments, infections become harder and more expensive to treat and can lead to increased illness and death.

Every day, SHEA members work in hospitals, clinics, and long-term care facilities to prevent infections, improve patient safety, and lead antimicrobial stewardship programs that ensure antibiotics are used judiciously. These programs help preserve the effectiveness of existing treatments, but stewardship alone is not enough. We also need a strong pipeline of new antibiotics and antifungal drugs to treat dangerous drug-resistant infections.

The PASTEUR Act would help address a critical market failure that has discouraged investments in new antimicrobial development. Because new antibiotics must be used sparingly to remain effective, companies often cannot recover the costs of developing them. The PASTEUR Act would create a subscription-based payment model that supports the development and availability of these lifesaving medicines while promoting responsible use.

Importantly, the legislation also invests in antimicrobial stewardship programs across hospitals, long-term care facilities, and outpatient settings, providing resources to strengthen and expand efforts that improve patient care, prevent infections, and combat antimicrobial resistance.

Please support patients, healthcare professionals, and our nation's public health infrastructure by co-sponsoring the PASTEUR Act.

Thank you for your consideration.